Donate

Cell therapy : replacing the deficient cells

Cell therapy takes up the challenge of replacing deficient or absent cells with healthy cells. It succeeds mainly through the contribution of specific cells: stem cells and iPS (induced pluripotent stem cells). From cardiac insufficiency to neuromuscular disease via cancer or nervous system pathologies, there are numerous applications.

Illustration for article: What is cell therapy?

What is cell therapy?

Cell therapy involves replacing deficient or missing cells with healthy cells. From cardiac insufficiency to neuromuscular diseases, cancers to nervous system pathologies, there are many applications. Defining the therapeutic potential of these cells for monogenic diseases is the objective of I-Stem, a research centre of which AFM-Téléthon is a founding member.
Illustration for article: What are stem cells and iPS ?

What are stem cells and iPS ?

Embryonic stem cells can give rise to all types of cells and tissues, but there are official issues involved in their use. Induced pluripotent stem cells are adult cells which have been reprogrammed to give them the potential of embryonic stem cells. But without the ethical problems! Because they can transform into different types of cells, stem cells have promising therapeutic prospects for rebuilding an injured organ or tissue.
Illustration for article: First advances in cell therapy

First advances in cell therapy

Cell therapy has been the subject of many research projects. The first human therapeutic trials have begun. The French Muscular Dystrophy Association (AFM-Téléthon) supports this research, which is already bearing fruit.